WOS: 000301610000012PubMed ID: 22155408We recently reported that hematological and neurological expressed 1 (HN1) is a ubiquitously expressed, EGF-regulated gene. Expression of HN1 in prostate cell lines down-regulates PI3 K-dependent Akt activation. Here, we investigate whether HN1 is regulated by androgens through the putative androgen response elements (AREs) found in its promoter. Knockdown of HN1 expression by siRNA silencing leads to an increase in Akt((S473)) phosphorylation, resulting in the translocation of androgen receptor (AR) to the nucleus: these effects can be abrogated by the non-specific Akt inhibitor LY294002 but not by the ERK inhibitor PD98059. Furthermore, HN1 overexpression correlates with an increase in ubiquitination...
Prostate cancer has developed ways to become resistant to current therapies due to the androgen rece...
The androgen receptor (AR) is required for prostate cancer development and contributes to tumor prog...
The human telomerase is a key factor during tumorigenesis in prostate cancer (PCa). The androgen rec...
WOS: 000344799200018PubMed ID: 25169422Previously, it has been reported that HN1 is involved in cyto...
WOS: 000291164000012PubMed ID: 21323578As the molecular mechanism of beta-catenin deregulation is no...
PubMed ID: 21323578As the molecular mechanism of ß-catenin deregulation is not well understood, and ...
The mechanisms responsible for the switch of prostate cancer from androgen-sensitive (AS) to androge...
<div><p>The androgen receptor (AR) plays a central role in the development and progression of prosta...
The androgen receptor (AR) plays a central role in the development and progression of prostate cance...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
HN1 has previously been shown as overexpressed in various cancers. In Prostate cancer, it regulates ...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
HN1 has previously been shown as overexpressed in various cancers. In Prostate cancer, it regulates ...
Prostate cancer (PCa) primarily depends on androgen receptor (AR) signaling pathway for the initiati...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
Prostate cancer has developed ways to become resistant to current therapies due to the androgen rece...
The androgen receptor (AR) is required for prostate cancer development and contributes to tumor prog...
The human telomerase is a key factor during tumorigenesis in prostate cancer (PCa). The androgen rec...
WOS: 000344799200018PubMed ID: 25169422Previously, it has been reported that HN1 is involved in cyto...
WOS: 000291164000012PubMed ID: 21323578As the molecular mechanism of beta-catenin deregulation is no...
PubMed ID: 21323578As the molecular mechanism of ß-catenin deregulation is not well understood, and ...
The mechanisms responsible for the switch of prostate cancer from androgen-sensitive (AS) to androge...
<div><p>The androgen receptor (AR) plays a central role in the development and progression of prosta...
The androgen receptor (AR) plays a central role in the development and progression of prostate cance...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
HN1 has previously been shown as overexpressed in various cancers. In Prostate cancer, it regulates ...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
HN1 has previously been shown as overexpressed in various cancers. In Prostate cancer, it regulates ...
Prostate cancer (PCa) primarily depends on androgen receptor (AR) signaling pathway for the initiati...
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict th...
Prostate cancer has developed ways to become resistant to current therapies due to the androgen rece...
The androgen receptor (AR) is required for prostate cancer development and contributes to tumor prog...
The human telomerase is a key factor during tumorigenesis in prostate cancer (PCa). The androgen rec...